Table 4.
Antimicrobial | Susceptibility rates % |
---|---|
Ceftazidime | 0 |
Cefepime | 0 |
Piperacillin-tazobactam | 0 |
Imipenem | 0 |
Meropenem | 46.2∗ |
Gentamicin | 46.2 |
Amikacin | 46.2 |
Ciprofloxacin | 0 |
Levofloxacin | 7.7 |
Trimethoprim-sulfamethoxazole | 23.1 |
Antimicrobial | Susceptibility rates % |
---|---|
Ceftazidime | 0 |
Cefepime | 0 |
Piperacillin-tazobactam | 0 |
Imipenem | 0 |
Meropenem | 46.2∗ |
Gentamicin | 46.2 |
Amikacin | 46.2 |
Ciprofloxacin | 0 |
Levofloxacin | 7.7 |
Trimethoprim-sulfamethoxazole | 23.1 |